Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands

PURPOSE: The fixed-dose dual bronchodilator combination (FDC) of tiotropium and olodaterol showed increased effectiveness regarding lung function and health-related quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with the use of its mono-components. Yet, while...

Descripción completa

Detalles Bibliográficos
Autores principales: van Boven, Job FM, Kocks, Janwillem WH, Postma, Maarten J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036592/
https://www.ncbi.nlm.nih.gov/pubmed/27703341
http://dx.doi.org/10.2147/COPD.S114738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036592/
https://www.ncbi.nlm.nih.gov/pubmed/27703341
http://dx.doi.org/10.2147/COPD.S114738

Ejemplares similares